Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121693) titled 'Optimal Timing of Radiotherapy Combined with Chemoimmunotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized Cohort, Prospective Study' on April 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Esophageal squamous cell carcinoma
Intervention:
Cohort 1:Patients will receive chemoimmunotherapy concurrently with radiotherapy
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-04-01
Target Sample Size: Cohort 1:30;Cohort 2:30;
Countries of Recruitment:
China
To know more, ...